Hybio Pharmaceutical Co., Ltd. (300199)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
25. 24
+0.86
+3.5275%
¥
17.78B Market Cap
- P/E Ratio
0.8% Div Yield
64.85M Volume
- Eps
¥ 24.38
Previous Close Want to track 300199 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | 0.09 |
| | | - | 0.08 |
| | | - | - |
| | | - | 0 |
| | | - | - |
| | | - | - |
| | | 0.24 | 0.13 |
| | | 0.18 | 0.05 |
| | | - | 0.07 |
| | | 0.08 | 0.19 |
| | | 0.22 | 0.1 |
| | | 0.15 | 0.06 |
| | | - | 0.04 |
| | | 0.07 | 0.09 |
| | | 0.1 | 0.07 |
| | | - | 0.03 |
300199 Earnings Reports FAQ
What is the earnings per share (EPS) for 300199?
EPS data for 300199 is currently not available, as Hybio Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 9.42%, reflecting the 300199's performance and XSHE market conditions.
When is the next earnings release date?
Hybio Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Hybio Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 300199 at this time, as Hybio Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
